Arsanis Receives Grant from the Austrian Research Promotion Agency for Pre-Clinical and Clinical Development of – PR Inside

Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of a grant for the development of monoclonal antibody therapeutics against nosocomial infections from the …Henan Kangtai Pharmaceutical Group Corporation is the largest producer of Norfloxacin USP/IP/CP.